Clinical trials remain central to evaluating the safety and efficacy of medical treatments, but they do not capture every aspect of how therapies are used across broader patient populations. Researchers also need to understand treatment patterns, healthcare utilization, long-term outcomes, and differences between patients in routine clinical practice.
Real-world evidence (RWE) is becoming an important resource for addressing these questions. In its 2023 guidance on real-world data and real-world evidence, the US Food and Drug Administration outlined considerations for using RWE to support regulatory decision-making for drugs and biological products, including applications involving new indications and post-approval study requirements. The guidance underscores the importance of evaluating the relevance and reliability of the underlying data and the methods used to generate evidence.
Producing useful evidence requires more than access to large healthcare datasets. Organizations must define appropriate patient cohorts, understand treatment histories, analyze clinical and economic outcomes, and account for limitations in the available information. As a result, healthcare analytics platforms are increasingly focused on connecting real-world data with the analytical capabilities required for research and decision-making.
Top RWE healthcare analytics company
Top RWE healthcare analytics companies help life sciences organizations analyze real-world healthcare information to evaluate treatment patterns, patient journeys, healthcare utilization, and clinical or economic outcomes. These capabilities can support comparative effectiveness research, health economics and outcomes research (HEOR), market access planning, and post-market evaluation.
PurpleLab provides real-world data and analytics for life sciences organizations through its HealthNexus platform and life sciences solutions. Its data and analytical capabilities support patient cohort identification, disease and market landscaping, treatment pathway analysis, healthcare utilization and cost analysis, and assessments of outcomes and comparative effectiveness. These functions help researchers examine how treatments are used in real-world settings and explore differences across patient populations.
The platform is designed to connect medical and pharmacy claims with provider information and analytical tools, helping teams investigate patient characteristics, treatment sequences, and patterns of healthcare use. PurpleLab also supports research and commercial activities across the product lifecycle, from trial feasibility and patient recruitment planning to market assessment and evidence generation. The usefulness of any resulting RWE depends on the research question, data quality, study design, and the appropriateness of the analytical methods; the availability of claims data alone does not establish clinical causality or guarantee regulatory acceptance.
